Cannsun Receives Approval for the First Women's Focused Phase II Psilocybin Trial on the African Continent

Press release content from Newswire. The AP news staff was not involved in its creation.

Related Keywords

South Africa ,United States ,Thailand ,Stellenbosch ,Western Cape ,America ,Neville Alexander ,Soraya Seedat ,Donaghue Woodman ,Duncan Mcdonald ,Aaron Katerenchuk ,David Parry ,African Health Products Regulatory Authority ,Cannsun Group ,Head Of Research Development At Cannsun Group ,Humboldt Research Award ,University Of California San Diego ,Stellenbosch University ,Lundbeck Institute Fellowship Award In Psychiatry ,Award For Research ,Head Of Business Development ,Major Depressive ,Business Development ,Executive Head ,World Federation ,Biological Psychiatry Fellowship ,Lundbeck Institute Fellowship Award ,California San Diego ,Anxiety Disorders Association ,America Career Development Award ,Chief Executive Officer ,Good Clinical Practice ,Release Service ,Cannsun Receives Approval ,First Women ,Focused Phase ,Health ,Business ,Africa ,Newswire ,Mental Health ,Clinical Trials ,